Infectious complications during neutropenia subsequent to peripheral blood stem cell transplantation

Bone Marrow Transplantation

Volumn 19, Issue 2, 1997, Pages 143-147

  Kolbe, K ^a,b   Domkin, D ^a   Derigs, H G ^a   Bhakdi, S ^b   Huber, C ^a   Aulitzky, W E ^a,c  

^a Division of Hematology   (Germany)

^b UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^c ROBERT BOSCH HOSPITAL   (Germany)

Author keywords

Autologous peripheral blood stem cell transplantation; Infection; Neutropenia

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; ARTICLE; BACTEREMIA; BACTERIAL INFECTION; CANCER CHEMOTHERAPY; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FEVER; GRAM POSITIVE COCCI; HUMAN; INFECTIOUS COMPLICATION; LEUKEMIA; LUNG INFILTRATE; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MULTIPLE MYELOMA; MYCOSIS; NEUTROPENIA; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; SOLID TUMOR; STEM CELL TRANSPLANTATION;

EID: 0031014429     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1700621     Document Type: Article

References (25)

1. Pizzo PA, Meyers JD, Freifeld AG, Walsh T. Infections in cancer patients. In: DeVita VT, Hellman S, Rosenberg SA (eds). Cancer. JB Lippincott: Philadelphia, 1993, pp 2292-2336.
2. Pizzo PA. Management of fever in patients with cancer and treatment-induced neutropenia. New Engl J Med 1993; 328: 1323-1332.
3. Wade JC, Schimpf SC. Epidemiology and prevention of infection in the compromised host. In: Rubin RH, Young LS (eds). Clinical Approach to Infection in the Compromised Host. Plenum Press: New York, London, 1988, pp 5-40.
4. Hryniuk W, Bush H. The importance of dose intensity in chemotherapy of metastatic breast cancer. J Clin Oncol 1984; 2: 1281-1288.
5. Frei EI. Pharmacologic strategies for high dose chemotherapy. In: Armitage JO, Antman KH (eds). High Dose Cancer Chemotherapy. Williams & Wilkins: Baltimore, 1992; pp 3-14.
6. Biermann PJ, Armitage JO. Autologous bone marrow transplantation for non-Hodgkins lymphoma. In: Forman SJ, Blume KG, Thomas ED (eds). Bone Marrow Transplantation. Blackwell Scientific: Boston, 1994, pp 683-695.
7. Yeager AM. Autologous bone marrow transplantation for acute myeloid leukemia. In: Forman SJ, Blume KG, Thomas ED (eds). Bone Marrow Transplantation. Blackwell Scientific: Boston, 1994, pp 709-730.
8. Philips GL. Transplantation for Hodgkin's disease. In: Forman SJ, Blume KG, Thomas ED (eds). Bone Marrow Transplantation. Blackwell Scientific: Boston, 1994, pp 696-708.
9. Pettengell R, Woll PJ, Thatcher N et al. Multicyclic, dose-intensive chemotherapy supported by sequential reinfusion of hematopoietic progenitors in whole blood. J Clin Oncol 1995; 13: 148-156.
10. Nademanee A, Sniecinski I, Schmidt GM et al. High-dose therapy followed by autologous peripheral-blood stem-cell transplantation for patients with Hodgkin's disease and non-Hodgkin's lymphoma using unprimed and granulocyte colony-stimulating factor-mobilized peripheral-blood stem cells. J Clin Oncol 1994; 12: 2176-2186.
11. Liberti G, Pearce R, Taghipour G et al. Comparison of peripheral blood stem-cell and autologous bone marrow transplantation for lymphoma patients: a case-controlled analysis of the EBMT Registry data. Lymphoma Working Party of the EBMT. Ann Oncol 1994; 5 (Suppl. 2): 151-153.
12. Siena S, Bregni M, Di Nicola M et al. Durability of hematopoiesis following autografting with peripheral blood hematopoietic progenitors. Ann Oncol 1994; 5: 935-941.
13. Coiffier B, Philip T, Burnett AK, Symann ML. Consensus conference on intensive chemotherapy plus hematopoietic stem-cell transplantation in malignancies: Lyon, France, 4-6 June, 1993 (see comments). J Clin Oncol 1994; 12: 226-231.
14. Lamy T, Drenou B, Grulois I et al. Improvement of hematologic recovery after high-dose intensification using peripheral blood progenitor cells (PBPC) mobilized by chemotherapy and GM-CSF. Ann Hematol 1994; 69: 297-302.
15. Beyer J, Schwella N, Zingsem J et al. Hematopoietic rescue after high-dose chemotherapy using autologous peripheral-blood progenitor cells or bone marrow: a randomized comparison. J Clin Oncol 1995; 13: 1328-1335.
16. To LB, Roberts MM, Haylock DN et al. Comparison of haematological recovery times and supportive care requirements of autologous recovery phase peripheral blood stem cell transplants, autologous bone marrow transplants and allogeneic bone marrow transplants. Bone Marrow Transplant 1992; 9: 277-284.
17. Watanabe T, Takaue Y, Abe T et al. Early infectious complications after peripheral blood stem cell autografts in children. Med Pediatr Oncol 1991; 19: 100-105.
18. D'Antonio D, Iacone A, Pierelli L, Bonfini T. Patterns of recovery phase infection after autologous blood progenitor cell transplantation in patients with malignancies. The Gruppo Italiano di Studio per la Manipolazione Cellulare in Ematologia. Eur J Clin Microbiol Infect Dis 1995; 14: 552-556.
19. Highes WT, Armstrong D, Bodey GP. Guidelines for the use of antimicrobal agents in neutropenic patients with unexplained fever. A statement by the Infectious Diseases Society of America. J Infect Dis 1990; 161: 381-396.
20. Link H, Maschmeyer G, Meyer P et al. Interventional antimicrobial therapy in febrile neutropenic patients. Study Group of the Paul Ehrlich Society for Chemotherapy. Ann Hematol 1994; 69: 231-243.
21. De Pauw BE, Deresinski SC, Feld R et al. Ceftazidime compared with piperacillin and tobramycin for the empiric treatment of fever in neutropenic patients with cancer. A multicenter randomized trial. The Intercontinental Antimicrobial Study Group. Ann Intern Med 1994; 120: 834-844.
22. Freifeld AG, Walsh T, Marshal D et al. Monotherapy for fever and neutropenia in cancer patients: a randomized comparison of ceftazidime versus imipenem. J Clin Oncol 1995; 13: 165-176.
23. Uderzo C, D'Angelo P, Rizzari C et al. Central venous catheter-related complications after bone marrow transplantation in children with hematological malignancies. Bone Marrow Transplant 1992; 9: 113-117.
24. Isenberg HD, D'Amato RF. Indigenous and pathogenic microorganisms of humans. In: Lennette EH, Balows A, Hausler WJ, Shadomy HJ (eds). Manual of Clinical Microbiology. American Society for Microbiology: Washington, 1985, pp 24-36.
25. Maschmeyer G, Link H, Hiddemann W et al. Pulmonary infiltrations in febrile patients with neutropenia. Risk factors and outcome under empirical antimicrobial therapy in a randomized multicenter study. Cancer 1994; 73: 2296-2304.